101 related articles for article (PubMed ID: 6784571)
1. An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides.
Woolfrey BF; Fox JM; Quall CO
Am J Clin Pathol; 1981 Apr; 75(4):559-64. PubMed ID: 6784571
[TBL] [Abstract][Full Text] [Related]
2. Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.
Woolfrey BF; Fox JM; Quall CO; Lally RT
Antimicrob Agents Chemother; 1983 Nov; 24(5):764-70. PubMed ID: 6419674
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
Ismaeel NA
Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
[TBL] [Abstract][Full Text] [Related]
4. Inability of the standardized disk agar-diffusion test to measure susceptibility of the fluorescent group of pseudomonads to gentamicin.
Woolfrey BF; Ramadei WA; Quall CO
Am J Clin Pathol; 1978 Sep; 70(3):337-42. PubMed ID: 101077
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
Clark RB; Sanders CC; Pakiz CB; Hostetter MK
Antimicrob Agents Chemother; 1988 May; 32(5):689-92. PubMed ID: 3134846
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
8. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum.
Cherne JE; Peterson LR
Antimicrob Agents Chemother; 1980 Jul; 18(1):210-1. PubMed ID: 6774664
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the moving intermediate zone concept for determing susceptibility of pseudomonads to gentamicin by the standardized disk agar-diffusion test.
Woolfrey BF; Ramadei WA; Quall CO
Am J Clin Pathol; 1979 Nov; 72(5):861-3. PubMed ID: 116543
[TBL] [Abstract][Full Text] [Related]
10. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
Stratton CW; Weeks LS; Tausk F
J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
[TBL] [Abstract][Full Text] [Related]
11. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
Staneck JL; Glenn S; DiPersio JR; Leist PA
J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Watanakunakorn C
Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.
Woolfrey BF; Lally RT; Ederer MN; Quall CO
J Clin Microbiol; 1984 Apr; 19(4):502-5. PubMed ID: 6425360
[TBL] [Abstract][Full Text] [Related]
16. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms.
Larson TA; Peterson LR; Gerding DN
J Clin Microbiol; 1985 Nov; 22(5):819-21. PubMed ID: 3932459
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
18. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
Christe M; Vaudaux P; Waldvogel FA
Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of five aminoglycosides for treatment.
Rosin H; Naumann P; Reintjens E; Köhler M
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
